DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /JAK/STAT SignalingJAK/STAT Signaling
  5. /EGFREGFR
  6. /OritinibOritinib
Chemical structure of CAS 2035089-28-0

Oritinib

In Stock•Starting at $251 for 1 mg
CAS No.2035089-28-0
MDL No.N/A
MFC31H37N7O2
MW539.70
InChI KeyPLUKVDOZEJBBIS-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$251In Stock
5 mgTo Be Confirmed$594In Stock
10 mgTo Be Confirmed$851In Stock
25 mgTo Be Confirmed$1357In Stock
50 mgTo Be Confirmed$1829In Stock
100 mgTo Be Confirmed$2445In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2035089-28-0
Product NameOritinib
Heavy Atom Count40Rotatable Bond Count10
Atom Stereo Count0Bond Stereo Count0
HBA8HBD2
TPSA87.550 ŲCharge0
Exact Mass539.30087Complexity1542.47
pKa5.875XLogP5.309

Related Articles

Studies related to this compound and its mechanism of action

New drugs approved by the NMPA in 2024: Synthesis and clinical applications.

European journal of medicinal chemistry • Vol. 291 • 2025
PMID: 40262297DOI: 10.1016/j.ejmech.2025.117643

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer.

Frontiers in pharmacology • Vol. 12 • 2021
PMID: 33986687PMC: PMC8111447DOI: 10.3389/fphar.2021.665253

Documentation

Similar Products

  • Osimertinib

    CAS No.1421373-65-0

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact